The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The research target is mouse glyceraldehyde-3-phosphate dehydrogenase (GAPDH) encoded by Gapdh, consistent with UniProt P16858 and the well-conserved GAPDH family. Evidence in this corpus describes a ~335 aa, ~37 kDa enzyme with an N‑terminal NAD+ binding region and a conserved catalytic cysteine centered at Cys150 (mouse numbering is consistently reported as Cys150 in multiple mechanistic and PTM contexts), matching the UniProt-provided identity and domains. (levenes2024desrétropseudogènespotentiellement pages 35-39, keenan2025cysteinesacetylationis pages 6-7)
Definition (canonical role): GAPDH catalyzes the oxidative phosphorylation step of glycolysis converting glyceraldehyde-3-phosphate (G3P) to 1,3-bisphosphoglycerate (1,3‑BPG) while reducing NAD+ to NADH.
A mechanistic structural study (conserved across species) describes the reaction sequence: the catalytic Cys150 nucleophilically attacks the aldehyde of G3P forming a hemithioacetal; hydride transfer to NAD+ produces NADH and a thioacyl (thioester) intermediate; then inorganic phosphate attacks the thioester to release 1,3‑BPG. His177 is identified as a key catalytic residue partner with Cys150, and Cys150/His177 mutations inactivate enzyme activity. (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, zhang2021novelstructuresof pages 12-14)
A dedicated enzymology-focused review reiterates that GAPDH catalyzes a glycolytic oxidoreduction reaction yielding NADH and the macroergic compound 1,3‑diphosphoglycerate, which is required for ATP generation in subsequent steps. (muronetz2019inhibitorsofglyceraldehyde pages 1-2)
A mouse-focused synthesis summarizes a typical architecture: an N‑terminal region mediating NAD+ binding (approx. residues 1–150), an active-site segment around 150–157 including an essential catalytic cysteine, and a functional catalytic form as an NAD+-bound homotetramer. (levenes2024desrétropseudogènespotentiellement pages 35-39)
“Moonlighting proteins” are single polypeptides that execute multiple functions not attributable to gene fusion, alternative splicing, or promiscuous side reactions, with function switching often governed by subcellular localization, oligomeric state, and post-translational modifications (PTMs). GAPDH is a canonical example: many non-glycolytic roles are proposed/observed when PTMs disrupt the tetrameric glycolytic state and promote relocalization (e.g., to nucleus). (levenes2024desrétropseudogènespotentiellement pages 35-39)
This conserved chemistry is explicitly described in the structural-mechanistic study and reiterated in the enzymology review. (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, muronetz2019inhibitorsofglyceraldehyde pages 1-2)
Key residues include Cys150 (active-site nucleophile) and His177 (catalytic partner), with the pathway proceeding through hemithioacetal and thioacyl intermediates and a phosphate attack step that yields 1,3‑BPG. (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, zhang2021novelstructuresof pages 12-14)
The mechanistic structural evidence identifies important features controlling phosphate positioning and intermediate turnover (anion-binding sites and a mobile loop), supporting a conserved “flip-flop” type catalytic model and underscoring why the Cys150 microenvironment is a central vulnerability to inhibition and PTMs. (zhang2021novelstructuresof pages 14-16, zhang2021novelstructuresof pages 12-14, muronetz2019inhibitorsofglyceraldehyde pages 1-2)
Canonical GAPDH catalysis occurs in the cytoplasm as part of glycolysis, producing NADH that can be re-oxidized in anaerobic contexts (via lactate production) or used in aerobic energy metabolism. (levenes2024desrétropseudogènespotentiellement pages 35-39, muronetz2019inhibitorsofglyceraldehyde pages 1-2)
A central theme in the modern understanding of GAPDH is that PTMs at the catalytic cysteine can inactivate glycolysis and favor nuclear-associated functions.
S-nitrosylation-driven nuclear translocation (classic mechanism): A mouse-focused synthesis summarizes that oxidative/nitrosative stress can induce S-nitrosylation of catalytic Cys150, inhibiting glycolytic activity, preventing NAD+ binding and tetramer stability, and enabling interaction with Siah1 (E3 ligase). Siah1 contains an NLS that supports nuclear import of the complex. (levenes2024desrétropseudogènespotentiellement pages 35-39)
Recent PTM development with quantitative localization data: A murine multi-tissue study of cysteine S-acetylation reports acetylation at GAPDH Cys150 (and Cys154) in mouse tissues, and provides functional and localization evidence: extensive acetylation of purified GAPDH correlated with an approximately 90% decrease in enzymatic activity after 24 h incubation with acetyl-CoA, and an acetylated GAPDH isoform was ~28-fold enriched in a nuclear-containing heavy membrane fraction compared with supernatant. This supports a contemporary view that active-site cysteine PTMs can jointly suppress glycolysis and favor nuclear-associated pools available for moonlighting functions. (keenan2025cysteinesacetylationis media 46448877, keenan2025cysteinesacetylationis pages 6-7)
A consolidated mouse-oriented synthesis states that GAPDH-SNO can function as a transnitrosylase, transferring NO from the S-nitrosylated active-site cysteine to nuclear proteins such as HDAC2, ATM, and SIRT1, and that this activity is abolished when the cysteine carrying NO (Cys150) is substituted. This is consistent with UniProt’s note of peptidyl-cysteine S-nitrosylase/transnitrosylase-like activity and emphasizes a mechanistic basis (NO group transfer from GAPDH-SNO). (levenes2024desrétropseudogènespotentiellement pages 35-39)
The same synthesis connects nuclear GAPDH to stress-response pathways including apoptosis (NO/GAPDH/Siah1 axis) and autophagy regulation (including AMPK-linked phosphorylation events), framing non-glycolytic roles as condition-dependent and typically enabled by PTMs that disrupt the glycolytic tetramer. (levenes2024desrétropseudogènespotentiellement pages 35-39)
A 2023 cancer-metabolism PTM review highlights that PTMs on metabolic enzymes can alter protein–protein interactions and subcellular localization, and includes GAPDH as an example where nitric oxide-driven modifications can drive nuclear translocation (review framing). (dessai2023regulationoftumor pages 1-3)
A 2023 persulfidation review emphasizes that central metabolic enzymes (including GAPDH) are regulated by cysteine-centered redox PTMs and reports, via cited literature, that CSE knockout mice show reduced GAPDH activity (~35%)—supporting the broader concept that gaseous transmitters and cysteine chemistry can re-tune GAPDH function. (vignane2023emergingchemicalbiology pages 10-12, vignane2023emergingchemicalbiology pages 1-2)
A 2023 meta-analysis focused on adipose tissue reports that ~70% of papers employed ACTB, GAPDH, and 18S as reference genes, yet also emphasizes that many studies did not include sex as a biological variable and that male bias is prevalent in datasets (e.g., 16,152 male vs 3,173 female samples in their surveyed context; 22% of publications did not specify animal sex; 80% included only males). The study’s main implication for Gapdh functional annotation practice is methodological: Gapdh/GAPDH expression may not be invariant across sex and conditions, and “reference gene” usage requires explicit validation. (guaitacespedes2023decipheringthesex pages 2-4)
A 2023 Scientific Reports study in human PBMCs (n=86 total; 47 normoglycemic, 39 type 2 diabetes) evaluated ACTB, PPIB, YWHAZ, GAPDH using RefFinder/NormFinder/BestKeeper/geNorm/ΔCt approaches and concluded ACTB and YWHAZ were most stable while GAPDH was among the least stable, particularly in T2DM subgroups. Sex-stratified analysis reported a significant reduction in GAPDH expression in T2DM females versus controls (P=0.034). While not a mouse dataset, this is directly relevant to the pervasive practice of using Gapdh as a normalizer in mammalian studies and reinforces the need for context-specific validation in mouse experiments. (hazarika2023identificationofstable pages 3-5, hazarika2023identificationofstable pages 5-7)
GAPDH remains widely used as a reference gene/protein (qPCR, Western blot normalization, and as an internal benchmark in workflows). The 2023 adipose-tissue meta-analysis demonstrates its continued prevalence (70% usage with other classic housekeeping genes), while also quantifying sex-related reporting biases that can confound interpretation. (guaitacespedes2023decipheringthesex pages 2-4)
GAPDH is a practical node for studying metabolic control via PTMs: enzymology-focused work emphasizes the high conservation of the Cys150 environment (limiting selective inhibition strategies) and discusses how oxidative inactivation can redirect metabolic flux (e.g., uncoupling glycolytic oxidation and phosphorylation). This provides a mechanistic rationale for why GAPDH PTMs are repeatedly leveraged as readouts in redox and metabolic-stress research. (muronetz2019inhibitorsofglyceraldehyde pages 1-2)
The following figure/table excerpts provide direct quantitative and site-level support for GAPDH functional modulation by active-site cysteine PTMs:
- Table listing GAPDH Cys150/Cys154 acetylation sites in mouse tissues and Figure panels showing activity loss and nuclear fraction enrichment after acetylation. (keenan2025cysteinesacetylationis media 46448877, keenan2025cysteinesacetylationis media 56a270a4)
| Aspect | Key points (mechanism/localization/PTMs) | Representative evidence (what type: structure, review, proteomics) | Recent/quantitative data (if any) | Key citations with year and URL |
|---|---|---|---|---|
| Identity / verification | UniProt P16858 matches Mus musculus Gapdh, the canonical cytosolic glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a 335-aa ~37 kDa glycolytic enzyme; literature summarized here aligns with the GAPDH family, NAD+-binding domain, catalytic cysteine chemistry, and mouse tissue proteomics/PTM data, consistent with the requested target rather than an unrelated gene symbol. | Mouse/mammalian review-style summary plus murine proteomics/PTM study | Mouse multi-tissue acetylome profiled 9 murine organs with n=3 biological replicates/tissue and detected GAPDH active-site cysteine acetylation in liver/BAT contexts (keenan2025cysteinesacetylationis pages 6-7, levenes2024desrétropseudogènespotentiellement pages 35-39) | Lévénès 2024, unknown journal/thesis summary, no stable URL in excerpt; Keenan et al. 2025, npj Metabolic Health and Disease, https://doi.org/10.1038/s44324-025-00081-2 (keenan2025cysteinesacetylationis pages 6-7, levenes2024desrétropseudogènespotentiellement pages 35-39) |
| Canonical enzymatic reaction | Canonical glycolytic step: G3P + Pi + NAD+ → 1,3-bisphosphoglycerate (1,3-BPG) + NADH + H+; GAPDH performs oxidative phosphorylation of glyceraldehyde-3-phosphate in the cytoplasm, coupling substrate oxidation to NAD+ reduction and high-energy acyl-phosphate formation. | Conserved mechanistic structural study; enzymology review; mammalian summary | GAPDH is highly abundant in cells, often estimated at 5–15% of soluble protein in older enzymology review literature cited in review context; reaction highlighted as central source of NADH and ATP-linked flux (muronetz2019inhibitorsofglyceraldehyde pages 1-2, levenes2024desrétropseudogènespotentiellement pages 35-39) | Zhang et al. 2021, Biomolecules, https://doi.org/10.3390/biom11111565; Muronetz et al. 2019, Biochemistry (Moscow), https://doi.org/10.1134/S0006297919110051 (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, muronetz2019inhibitorsofglyceraldehyde pages 1-2, levenes2024desrétropseudogènespotentiellement pages 35-39) |
| Catalytic mechanism / residues | Conserved catalytic mechanism: active-site Cys150 attacks the aldehyde of G3P to form a hemithioacetal; hydride transfer to NAD+ yields NADH and a thioacyl intermediate; His177 is the catalytic partner; inorganic phosphate then attacks the thioester to release 1,3-BPG. | Primary structure-function / crystallography | Mutations at C150 and H177 inactivate enzyme in structural-mechanistic studies; bacterial type-I GAPDH mechanism is used as a close, highly conserved model for mammalian GAPDH chemistry (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, zhang2021novelstructuresof pages 12-14) | Zhang et al. 2021, Biomolecules, https://doi.org/10.3390/biom11111565 (zhang2021novelstructuresof pages 1-2, zhang2021novelstructuresof pages 14-16, zhang2021novelstructuresof pages 12-14) |
| Domains / oligomeric state / canonical localization | N-terminal NAD+-binding domain extends roughly through residues 1–150; active-site segment around 150–157; GAPDH is catalytically active as a homotetramer; canonical function is cytosolic. | Structural summary; mammalian review-style synthesis | Tetramerization is linked to NAD+ and substrate binding; disruption of tetrameric state is associated with moonlighting/nuclear functions under PTM stress conditions (levenes2024desrétropseudogènespotentiellement pages 35-39) | Lévénès 2024, unknown journal/thesis summary, no stable URL in excerpt; Zhang et al. 2021, Biomolecules, https://doi.org/10.3390/biom11111565 (zhang2021novelstructuresof pages 1-2, levenes2024desrétropseudogènespotentiellement pages 35-39) |
| S-nitrosylation and nuclear translocation | S-nitrosylation of catalytic Cys150 inhibits glycolytic activity, disrupts NAD+-bound tetrameric state, and enables binding of the E3 ligase Siah1 (binding region reported around residues 220–238; Lys225 implicated), whose NLS mediates nuclear translocation of the complex; nuclear GAPDH contributes to apoptosis and stress signaling. | Mammalian mechanistic review/summary with prior primary studies synthesized | S-nitrosylation also reported at C154 and C245 in some summaries; PTM-dependent GAPDH monomerization/nuclear movement is emphasized as a core moonlighting switch (levenes2024desrétropseudogènespotentiellement pages 35-39) | Lévénès 2024, unknown journal/thesis summary, no stable URL in excerpt; Dessai et al. 2023 review notes GAPDH PTM-driven nuclear translocation, https://doi.org/10.1038/s41417-022-00521-x (levenes2024desrétropseudogènespotentiellement pages 35-39, dessai2023regulationoftumor pages 1-3) |
| Transnitrosylase / nuclear targets | GAPDH-SNO is described as a transnitrosylase that can transfer NO equivalents from S-nitrosylated Cys150 to nuclear proteins, including HDAC2, ATM, and SIRT1; this links GAPDH to transcriptional control, DNA-damage signaling, acetylation programs, and cell death pathways. | Mechanistic review-style synthesis of prior primary literature | Cys150 substitution abolishes reported GAPDH-SNO transnitrosylase activity toward nuclear targets in cited summaries (levenes2024desrétropseudogènespotentiellement pages 35-39) | Lévénès 2024, unknown journal/thesis summary, no stable URL in excerpt (levenes2024desrétropseudogènespotentiellement pages 35-39) |
| Recent PTM development: cysteine acetylation in mouse tissues | A recent murine cysteine acetylome study identified active-site GAPDH acetylation at C150/C154 in mouse tissues; this PTM phenocopies known nitrosylation logic by suppressing catalytic activity and associating with nuclear-enriched fractions. | 2025 primary proteomics and functional biochemistry in mouse tissues/protein | In liver survey, GAPDH C150/C154 was among highly abundant cysteine acetylation sites; in purified GAPDH, 24 h acetyl-CoA exposure decreased activity by ~90%; acetylated GAPDH isoform was 28-fold enriched in nuclear-containing heavy membrane fraction versus supernatant; PCA of cysteine acetylome across 9 tissues separated organs strongly, and cold exposure reorganized BAT acetylome (keenan2025cysteinesacetylationis pages 6-7, keenan2025cysteinesacetylationis media 46448877) | Keenan et al. 2025, npj Metabolic Health and Disease, https://doi.org/10.1038/s44324-025-00081-2 (keenan2025cysteinesacetylationis pages 6-7, keenan2025cysteinesacetylationis media 46448877) |
| Other PTM/redox context | GAPDH is also discussed as a target of oxidation, glutathionylation, glycation, O-GlcNAcylation, sulfhydration/persulfidation, and ADP-ribosylation; these modifications can reduce catalytic activity, re-route metabolism, or favor non-glycolytic roles including autophagy and nuclear signaling. | Reviews on GAPDH inhibition/redox biology; persulfidation review | Persulfidation field review highlights broad disease relevance and notes reduced GAPDH activity in CSE knockout mice by ~35% in cited literature context; O-GlcNAcylation at Thr227 and phosphorylation at Ser122 are linked in summaries to nuclear relocalization/autophagy signaling (vignane2023emergingchemicalbiology pages 10-12, levenes2024desrétropseudogènespotentiellement pages 35-39) | Vignane & Filipovic 2023, Antioxidants & Redox Signaling, https://doi.org/10.1089/ars.2023.0352; Muronetz et al. 2019, https://doi.org/10.1134/S0006297919110051 (vignane2023emergingchemicalbiology pages 10-12, vignane2023emergingchemicalbiology pages 1-2, muronetz2019inhibitorsofglyceraldehyde pages 1-2, levenes2024desrétropseudogènespotentiellement pages 35-39) |
| Real-world application: reference gene / normalization | Gapdh/GAPDH remains widely used as a qPCR housekeeping/reference gene and as a practical assay readout in RNA extraction workflows, but recent studies stress that it is not universally stable and must be validated by tissue, disease state, and sex. | 2023 meta-analysis; 2023 PBMC validation; 2024 RNA workflow paper | In adipose-tissue review/meta-analysis, 70% of papers used ACTB, GAPDH, or 18S as references; among preclinical studies, 22% did not specify animal sex, 80% used only males, with 16,152 male vs 3,173 female samples overall (guaitacespedes2023decipheringthesex pages 2-4). In a PBMC study (n=86 total: 47 normoglycemic, 39 T2DM), GAPDH was among the least stable genes and in T2DM females its expression was significantly lower than controls (P = 0.034), while ACTB/YWHAZ were recommended as more stable alternatives (hazarika2023identificationofstable pages 3-5, hazarika2023identificationofstable pages 5-7). A 2024 RNA extraction paper still used GAPDH as a housekeeping benchmark in mouse cortex, illustrating continued implementation despite these cautions (anastacio2017proteinprofileof pages 9-14, hazarika2023identificationofstable pages 3-5, hazarika2023identificationofstable pages 5-7, guaitacespedes2023decipheringthesex pages 2-4, guaitacespedes2023decipheringthesex pages 1-2). | Guaita-Cespedes et al. 2023, Biology of Sex Differences, https://doi.org/10.1186/s13293-023-00506-x; Hazarika et al. 2023, Scientific Reports, https://doi.org/10.1038/s41598-023-27460-3; Zeng et al. 2024, PeerJ, https://doi.org/10.7717/peerj.18072 (hazarika2023identificationofstable pages 3-5, hazarika2023identificationofstable pages 5-7, guaitacespedes2023decipheringthesex pages 2-4, guaitacespedes2023decipheringthesex pages 1-2, anastacio2017proteinprofileof pages 9-14) |
Table: This table summarizes the canonical enzymatic role of Mus musculus GAPDH (Gapdh; UniProt P16858), its best-supported moonlighting functions, and recent quantitative findings relevant to functional annotation. It also captures practical laboratory use as a reference gene together with recent cautions about context- and sex-dependent instability.
References
(levenes2024desrétropseudogènespotentiellement pages 35-39): A Lévénès. Des rétropseudogènes potentiellement impliqués dans la plurifonctionnalité décrite chez gapdh. Unknown journal, 2024.
(keenan2025cysteinesacetylationis pages 6-7): E. Keith Keenan, Akshay Bareja, Yannie Lam, Paul A. Grimsrud, and Matthew D. Hirschey. Cysteine s-acetylation is a widespread post-translational modification on metabolic proteins. npj Metabolic Health and Disease, Nov 2025. URL: https://doi.org/10.1038/s44324-025-00081-2, doi:10.1038/s44324-025-00081-2. This article has 1 citations and is from a peer-reviewed journal.
(zhang2021novelstructuresof pages 1-2): Li Zhang, Meiruo Liu, Luyao Bao, Kristina I. Boström, Yucheng Yao, Jixi Li, Shaohua Gu, and Chaoneng Ji. Novel structures of type 1 glyceraldehyde-3-phosphate dehydrogenase from escherichia coli provide new insights into the mechanism of generation of 1,3-bisphosphoglyceric acid. Biomolecules, 11:1565, Oct 2021. URL: https://doi.org/10.3390/biom11111565, doi:10.3390/biom11111565. This article has 14 citations.
(zhang2021novelstructuresof pages 14-16): Li Zhang, Meiruo Liu, Luyao Bao, Kristina I. Boström, Yucheng Yao, Jixi Li, Shaohua Gu, and Chaoneng Ji. Novel structures of type 1 glyceraldehyde-3-phosphate dehydrogenase from escherichia coli provide new insights into the mechanism of generation of 1,3-bisphosphoglyceric acid. Biomolecules, 11:1565, Oct 2021. URL: https://doi.org/10.3390/biom11111565, doi:10.3390/biom11111565. This article has 14 citations.
(zhang2021novelstructuresof pages 12-14): Li Zhang, Meiruo Liu, Luyao Bao, Kristina I. Boström, Yucheng Yao, Jixi Li, Shaohua Gu, and Chaoneng Ji. Novel structures of type 1 glyceraldehyde-3-phosphate dehydrogenase from escherichia coli provide new insights into the mechanism of generation of 1,3-bisphosphoglyceric acid. Biomolecules, 11:1565, Oct 2021. URL: https://doi.org/10.3390/biom11111565, doi:10.3390/biom11111565. This article has 14 citations.
(muronetz2019inhibitorsofglyceraldehyde pages 1-2): V. I. Muronetz, A. K. Melnikova, K. V. Barinova, and E. V. Schmalhausen. Inhibitors of glyceraldehyde 3-phosphate dehydrogenase and unexpected effects of its reduced activity. Biochemistry (Moscow), 84:1268-1279, Nov 2019. URL: https://doi.org/10.1134/s0006297919110051, doi:10.1134/s0006297919110051. This article has 31 citations.
(keenan2025cysteinesacetylationis media 46448877): E. Keith Keenan, Akshay Bareja, Yannie Lam, Paul A. Grimsrud, and Matthew D. Hirschey. Cysteine s-acetylation is a widespread post-translational modification on metabolic proteins. npj Metabolic Health and Disease, Nov 2025. URL: https://doi.org/10.1038/s44324-025-00081-2, doi:10.1038/s44324-025-00081-2. This article has 1 citations and is from a peer-reviewed journal.
(dessai2023regulationoftumor pages 1-3): Abhisha Sawant Dessai, Poonam Kalhotra, Aaron T. Novickis, and Subhamoy Dasgupta. Regulation of tumor metabolism by post translational modifications on metabolic enzymes. Cancer Gene Therapy, 30:548-558, Aug 2023. URL: https://doi.org/10.1038/s41417-022-00521-x, doi:10.1038/s41417-022-00521-x. This article has 39 citations and is from a peer-reviewed journal.
(vignane2023emergingchemicalbiology pages 10-12): Thibaut Vignane and Milos R. Filipovic. Emerging chemical biology of protein persulfidation. Jul 2023. URL: https://doi.org/10.1089/ars.2023.0352, doi:10.1089/ars.2023.0352. This article has 89 citations and is from a domain leading peer-reviewed journal.
(vignane2023emergingchemicalbiology pages 1-2): Thibaut Vignane and Milos R. Filipovic. Emerging chemical biology of protein persulfidation. Jul 2023. URL: https://doi.org/10.1089/ars.2023.0352, doi:10.1089/ars.2023.0352. This article has 89 citations and is from a domain leading peer-reviewed journal.
(guaitacespedes2023decipheringthesex pages 2-4): Maria Guaita-Cespedes, Rubén Grillo-Risco, Marta R. Hidalgo, S. Fernández-Veledo, Borja Gómez-Cabañes, Gonzalo Anton-Bernat, Deborah Burks, María de la Iglesia-Vayá, A. Galán, and F. García-García. Deciphering the sex bias in housekeeping gene expression in adipose tissue: a comprehensive meta-analysis of transcriptomic studies. Biology of Sex Differences, Apr 2023. URL: https://doi.org/10.1186/s13293-023-00506-x, doi:10.1186/s13293-023-00506-x. This article has 9 citations and is from a peer-reviewed journal.
(hazarika2023identificationofstable pages 3-5): Ankita Hazarika, Bajanai Nongkhlaw, and Arpita Mukhopadhyay. Identification of stable reference genes in peripheral blood mononuclear cells from type 2 diabetes mellitus patients. Scientific Reports, Jan 2023. URL: https://doi.org/10.1038/s41598-023-27460-3, doi:10.1038/s41598-023-27460-3. This article has 16 citations and is from a peer-reviewed journal.
(hazarika2023identificationofstable pages 5-7): Ankita Hazarika, Bajanai Nongkhlaw, and Arpita Mukhopadhyay. Identification of stable reference genes in peripheral blood mononuclear cells from type 2 diabetes mellitus patients. Scientific Reports, Jan 2023. URL: https://doi.org/10.1038/s41598-023-27460-3, doi:10.1038/s41598-023-27460-3. This article has 16 citations and is from a peer-reviewed journal.
(keenan2025cysteinesacetylationis media 56a270a4): E. Keith Keenan, Akshay Bareja, Yannie Lam, Paul A. Grimsrud, and Matthew D. Hirschey. Cysteine s-acetylation is a widespread post-translational modification on metabolic proteins. npj Metabolic Health and Disease, Nov 2025. URL: https://doi.org/10.1038/s44324-025-00081-2, doi:10.1038/s44324-025-00081-2. This article has 1 citations and is from a peer-reviewed journal.
(anastacio2017proteinprofileof pages 9-14): Amandine Anastácio, Kenny A Rodriguez-Wallberg, Solenne Chardonnet, Cédric Pionneau, Christian Fédérici, Teresa Almeida Santos, and Catherine Poirot. Protein profile of mouse ovarian follicles grown in vitro. Molecular Human Reproduction, 23:827-841, Oct 2017. URL: https://doi.org/10.1093/molehr/gax056, doi:10.1093/molehr/gax056. This article has 34 citations and is from a peer-reviewed journal.
(guaitacespedes2023decipheringthesex pages 1-2): Maria Guaita-Cespedes, Rubén Grillo-Risco, Marta R. Hidalgo, S. Fernández-Veledo, Borja Gómez-Cabañes, Gonzalo Anton-Bernat, Deborah Burks, María de la Iglesia-Vayá, A. Galán, and F. García-García. Deciphering the sex bias in housekeeping gene expression in adipose tissue: a comprehensive meta-analysis of transcriptomic studies. Biology of Sex Differences, Apr 2023. URL: https://doi.org/10.1186/s13293-023-00506-x, doi:10.1186/s13293-023-00506-x. This article has 9 citations and is from a peer-reviewed journal.